Potential cost-effectiveness of universal access to modern contraceptives in Uganda.

by Joseph B Babigumira, Andy Stergachis, David L Veenstra, Jacqueline S Gardner, Joseph Ngonzi, Peter Mukasa-Kivunike, Louis P Garrison
Published 2012-01-01

A Novel LC‐MS/MS Assay for Quantification of Des‐carboxy Prothrombin and Characterization of Warfarin‐Induced Changes

by Abdul Basit, Bhagwat Prasad, Joanne K. Estergreen, Daniel E. Sabath, Nathan Alade, David L. Veenstra, Allan E. Rettie, Kenneth E. Thummel
Published 2020-07-01

Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study

by Josh J. Carlson, David D. Kim, Gregory F. Guzauskas, Caroline S. Bennette, David L. Veenstra, Anirban Basu, Nathaniel Hendrix, Dawn L. Hershman, Laurence Baker, Scott D. Ramsey
Published 2018-09-01

VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People

by Lindsay M. Henderson, Renee F. Robinson, Lily Ray, Burhan A. Khan, Tianran Li, Denise A. Dillard, Brian D. Schilling, Mike Mosley, Patricia L. Janssen, Alison E. Fohner, Allan E. Rettie, Kenneth E. Thummel, Timothy A. Thornton, David L. Veenstra
Published 2019-05-01

Harmonizing Outcomes for Genomic Medicine: Comparison of eMERGE Outcomes to ClinGen Outcome/Intervention Pairs

by Janet L. Williams, Wendy K. Chung, Alex Fedotov, Krzysztof Kiryluk, Chunhua Weng, John J. Connolly, Margaret Harr, Hakon Hakonarson, Kathleen A. Leppig, Eric B. Larson, Gail P. Jarvik, David L. Veenstra, Christin Hoell, Maureen E. Smith, Ingrid A. Holm, Josh F. Peterson, Marc S. Williams
Published 2018-07-01